PTEN and gastrointestinal stromal tumor: In GIST-100, patients with PTEN heterozygous loss had significantly poorer DFS (mDFS, 27.56 months; 95% CI, 18.76 to NR) compared with patients with PTEN normal status (mDFS, NR; 95% CI, 83.65 to NR; P < .001).